FLATEXDEGIRO-AG
Oliver Behrens appointed as new Chief Executive Officer (CEO)
flatexDEGIRO AG (the “Company”), one of the leading and fastest growing online brokers in Europe, announces that the Company’s Supervisory Board has appointed Oliver Behrens (60) as Chief Executive Officer (CEO) of flatexDEGIRO AG, effective from October 1, 2024, for a duration of three years. Furthermore, Oliver Behrens will also take over as CEO of flatexDEGIRO Bank AG.
Oliver Behrens brings 40 years of experience in the European financial industry with a strong link to brokerage and an outstanding network in international finance and politics.
From 2015 to June 2024, Oliver Behrens lately was CEO of Morgan Stanley Europe Holding SE, Morgan Stanley Europe SE and Morgan Stanley Bank AG, Frankfurt am Main, as well as Member of the Board of Morgan Stanley International Limited, London. Moreover, until 2014, he also served as Member of the Board of Deka-Bank for nine years, lately as Deputy CEO. From 1992 to 2005, he worked in Frankfurt and Luxembourg, among others, across various functions in the former DWS Group, DWS and Deutsche Asset Management, where he was lately Spokesman of the Management Board of Deutsche Asset Management Investment GmbH. Since June 2024, Oliver Behrens is Chairman of DWS Group GmbH & Co. KGaA’s Supervisory Board.
Oliver Behrens takes over from Dr Benon Janos (52) and Stephan Simmang (58), who, since May 1, 2024, serve as interim Co-CEOs of the Company, in addition to their existing responsibilities as CFO and CTO, respectively.
On his appointment as new CEO of flatexDEGIRO AG, Oliver Behrens commented: "The European online brokerage business is still in its early innings, holding enormous potential for growth and value enhancement. Together with flatexDEGIRO’s strong leadership team, I am very much looking forward to leading the company into the next phase of its evolution, further enhancing the investment experience for millions of clients across 16 countries while firmly establishing flatexDEGIRO as the driving force in the European online brokerage market.”
Martin Korbmacher, Chairman of flatexDEGIRO’s Supervisory Board, said: “With Oliver Behrens, we have succeeded in engaging a real heavyweight of the European financial industry for this leading role at flatexDEGIRO. It fills us with pride and speaks for the great potential of flatexDEGIRO that we have been able to recruit an executive of his caliber for the vacant CEO position. With his outstanding industry experience and his strong, team-orientated leadership personality, Oliver Behrens is a real gain, both operationally and organizationally, for our company which he already knows very well from the long-standing and cooperative business relationships with his previous employer.”
The appointment of Oliver Behrens as CEO of flatexDEGIRO AG and flatexDEGIRO Bank AG is subject to customary approvals by the German Federal Financial Supervisory Authority (BaFin).
Appointment of Dr Benon Janos (CFO) as Deputy CEO
Moreover, the Company’s Supervisory Board has appointed Dr Benon Janos (CFO) as Deputy CEO of flatexDEGIRO AG, effective from October 1, 2024. Dr Benon Janos will also fulfil this function at flatexDEGIRO Bank AG.
Contract extension of Dr Benon Janos (Deputy CEO & CFO) and Stephan Simmang (CTO) until mid-2029
Furthermore, the Supervisory Board of flatexDEGIRO has also decided to extend the Management Board contracts of Dr Benon Janos (Deputy CEO & CFO) and Stephan Simmang (CTO) until May 31, 2029. Dr Benon Janos and Stephan Simmang have held management positions at flatexDEGIRO since 2016, serving as members of the Company’s Management Board since 2023.
Therefore, effective from October 1, 2024, flatexDEGIRO AG’s Management Board will consist of four members, namely Oliver Behrens (CEO), Dr Benon Janos (Deputy CEO & CFO), Stephan Simmang (CTO) and Christiane Strubel (CHRO).
Martin Korbmacher, Chairman of flatexDEGIRO’s Supervisory Board, said: “On behalf of the whole Supervisory Board, I would like to express our deepest gratitude to Dr Benon Janos and Stephan Simmang for stepping up and taking on additional responsibilities as Co-CEOs during the past months, ensuring a professional and orderly transition after the departure of the former CEO. The Supervisory Board is very much looking forward to extending the great collaboration over the coming years and expressly thanks Dr Benon Janos and Stephan Simmang for their leadership and integrity, especially during this critical transition phase.”
About flatexDEGIRO AG
flatexDEGIRO AG (WKN: FTG111, ISIN: DE000FTG1111, Ticker: FTK.GR) operates one of the leading and fastest growing online brokerage platforms in Europe. Based on modern, in-house state-of-the-art technology, customers of the flatex and DEGIRO brands are offered a wide range of independent products with execution on top TIER 1 exchanges. The technological edge, high efficiency and strong economies of scale enable flatexDEGIRO to continuously improve its service offering for clients and set leading standards in terms of product, price and platform quality.
With around 3 million customer accounts and around 60 million securities transactions processed in 2023, flatexDEGIRO is one of the largest retail online brokers in Europe. In times of bank consolidation, low real interest rates and digitalization, flatexDEGIRO is ideally positioned for further growth.
Further information can be found at https://www.flatexdegiro.com/en.
| Language: | English | |
| Company: | flatexDEGIRO AG | |
| Omniturm, Große Gallusstraße 16-18 | ||
| 60312 Frankfurt / Main | ||
| Germany | ||
| Phone: | +49 (0) 69 450001 0 | |
| E-mail: | ir@flatexdegiro.com | |
| Internet: | www.flatexdegiro.com | |
| ISIN: | DE000FTG1111 | |
| WKN: | FTG111 | |
| Indices: | SDAX | |
| Listed: | Regulated Market in Berlin, Dusseldorf, Frankfurt (Prime Standard), Hamburg, Munich, Stuttgart, Tradegate Exchange |
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240828514871/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Blue Matter Establishes New Capabilities in Biopharma Research & Development Led by Partner, Tara Austraat-Churik13.1.2026 15:01:00 CET | Press release
Blue Matter is pleased to announce that it has established a practice area dedicated to serving clients in biopharmaceutical Research & Development (R&D). The practice is led by Tara Austraat-Churik, a Partner who joined the firm in September 2025. Tara Austraat-Churik has been serving life science clients for more than 20 years. Her areas of expertise include strategy development and implementation, operating model and organizational design, and process optimization in R&D and Medical Affairs. Prior to joining Blue Matter, she served as Managing Director in R&D, Health, Science, and Wellness at EY. She has a robust background in consulting, which also includes roles at Booz Allen Hamilton, Navitas, WPP, and IBM. She holds a BA and MA from the University of Notre Dame and an MSc in Translational Medicine from the University of Edinburgh. The R&D practice, according to Austraat-Churik, exists to help biopharma companies simplify and accelerate the pathway to market. She adds, “R&D organ
Wasabi Raises $70M in New Equity to Power the Next Era of Data Infrastructure13.1.2026 15:00:00 CET | Press release
At a $1.8 billion valuation, backed by L2 Point and Pure Storage, the company scales AI-first cloud storage to meet the explosive demands of modern data Wasabi Technologies, the Hot Cloud Storage company, today announced a $70 million equity funding round led by L2 Point Management with participation from Pure Storage and existing investors including Fidelity Management & Research Company. The new round values Wasabi at $1.8 billion and brings the company’s total funding to over $600 million. The capital will be used to accelerate Wasabi’s expansion into AI infrastructure, broaden its global footprint, and enhance its product portfolio to meet the growing data demands of enterprises and AI developers worldwide. “We’re ushering in the next generation of cloud storage, powering data-intensive workloads like generative AI and autonomous systems,” said David Friend, co-founder and CEO of Wasabi Technologies. “This funding underscores Wasabi’s strong market position and continued growth as
HumanX Amsterdam Reveals First 100 Speakers, Bringing Global AI Powerhouses to Europe13.1.2026 14:00:00 CET | Press release
Anton Osika (Lovable), May Habib (Writer), Jan Oberhauser (n8n) & Eléonore Crespo (Pigment) headline a diverse lineup spanning AI innovation and enterprise adoption HumanX, the global AI summit for executives and innovators, today unveiled its first 100 speakers and opened registration for HumanX Amsterdam, taking place 22–24 September 2026 at The RAI. Built by the team behind Money20/20, Shoptalk, and HLTH, HumanX Amsterdam brings the proven formula of its #1 U.S. flagship event and ecosystem gathering to Europe. The event convenes over 2,500 senior leaders focused on moving beyond the hype to drive practical, responsible AI implementation across industries. Speakers Leading the Conversation The first 100 speakers include AI company founders such as Anton Osika (Lovable), Jan Oberhauser (n8n), May Habib (Writer), Arvind Jain (Glean), and Jarek Kutylowski (DeepL), alongside executives scaling AI in the enterprise, including Clay Bavor (Sierra), Des Traynor (Intercom), and Eléonore Cres
GARDP and Debiopharm Partner to Advance Development of Novel Gonorrhea Drug13.1.2026 14:00:00 CET | Press release
The GARDP Foundation (known as GARDP) and the privately-owned, global biopharmaceutical company Debiopharm today announced that they have entered into a collaboration and license agreement to pursue the development of Debio1453, a novel, first-in-class antibiotic targeting Neisseria gonorrhoeae. With 82 million new cases each year, and the continued spread of multidrug-resistant N. gonorrhoeae strains, gonorrhea represents a global health crisis. This new partnership will help ensure that gonorrhea continues to be a treatable disease and will alleviate the risk of the emergence of future resistance, by ensuring that the antibiotic pipeline continues to be replenished. Gonorrhea caused by N. gonorrhoeae is currently in danger of becoming untreatable because of antimicrobial resistance (AMR). Having developed resistance to almost all antibiotics used to treat it, only one last recommended treatment, ceftriaxone, remains effective, and now we are seeing a growing number of cases that are
Wolfspeed Achieves 300mm Silicon Carbide (SiC) Technology Breakthrough13.1.2026 14:00:00 CET | Press release
300mm SiC Technology, Enabling Scalable Platforms for AI Infrastructure, AR/VR, and Advanced Power DevicesAnnouncement highlights:Strategic Technology Milestone – Wolfspeed has produced a single crystal 300mm (12-inch) silicon carbide wafer, representing a major advancement in the evolution of silicon carbide technology and a critical enabler for emerging applications. Technology leadership for Next-Gen Applications – Backed by one of the industry’s largest and most foundational silicon carbide IP portfolios, with over 2,300 issued and pending patents worldwide, Wolfspeed is accelerating the commercialization of 300mm technology to power next-generation platforms including AI infrastructure, augmented reality/virtual reality (AR/VR) and advanced power devices. Strengthening U.S. Semiconductor Leadership & Supply Chain Resilience –The company’s vertically integrated supply chain, from crystal growth to advanced packaging, supports national goals around compound semiconductor independenc
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom